Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma
Conditions
Advanced Lung Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
No study contact email or phone is listed for this trial.